Linezolid B. Braun

Linezolid, the active ingredient in Linezolid B. Braun, is an oxazolidinone antibiotic presented as an injectable solution for intravenous use. It treats infections caused by susceptible Gram‑positive bacteria, including skin and soft tissue infections and both community‑acquired and nosocomial pneumonia, in adult patients.

GNH USA supplies Linezolid B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is an oxazolidinone antibiotic used to treat serious Gram‑positive bacterial infections. - Skin and soft tissue infections: eradicates susceptible Staphylococcus and Streptococcus species, promoting wound healing. - Community‑acquired and nosocomial pneumonia: clears pulmonary infection caused by resistant Gram‑positive pathogens. - Infections caused by susceptible Gram‑positive bacteria: provides bacteriostatic activity against a broad range of resistant strains.

Linezolid may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: altered taste perception. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Anemia: reduced red blood cell levels. - Peripheral neuropathy: nerve damage causing tingling. - Serotonin syndrome: risk when combined with serotonergic agents. - Severe hypotension: marked blood pressure decrease. - Hepatic dysfunction: elevated liver enzymes indicating liver injury.

When using Linezolid, clinicians should observe several safety measures. - Blood count monitoring: regularly assess platelet and hemoglobin levels. - Hepatic and renal function: evaluate liver and kidney status before and during therapy. - Serotonergic drugs: avoid concomitant use with SSRIs, MAOIs, or other serotonergic agents. - Myelosuppression history: use caution in patients with prior bone‑marrow suppression. - Severe hepatic impairment: consider dose adjustment or alternative therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Linezolid interacts with several drug classes, requiring careful management.

Major Interactions (Avoid): - Serotonergic agents: SSRIs, SNRIs, MAO inhibitors increase serotonin syndrome risk. - Tyramine‑rich foods: may provoke hypertensive reactions due to MAO inhibition. - Rifampin: induces metabolism, markedly reducing linezolid levels.

Moderate Interactions (Monitor Closely): - NSAIDs: heightened bleeding risk with thrombocytopenia. - Warfarin: potential alteration of INR, requiring closer monitoring. - Antacids containing aluminum or magnesium: may affect absorption, advise separation of dosing. - QT‑prolonging drugs: monitor cardiac rhythm for additive effects.